- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
This book offers a comprehensive review of the molecular and cellular mechanisms underlying autoimmune disorders, as well as the role of immunotherapy in managing these diseases. The initial chapter introduces the concept of tolerance, the immune system's capacity to distinguish between self and non-self. Further, it explores various factors that can disrupt this balance, leading to a breakdown of tolerance and the onset of autoimmune diseases. The book evaluates current strategies for managing autoimmune diseases, emphasizes their limitations, and introduces immunotherapeutic approaches. Furthermore, it delves into the latest advancements in immunosuppression, vaccine development, and the role of specific immune cells in autoimmune conditions. It discusses the generation of regulatory T cells (Tregs) and their therapeutic potential, as well as examines vaccines and myeloid-derived suppressor cells for preventing and treating autoimmune diseases. Additionally, the book addresses a revolutionary approach, chimeric antigen receptor T-cell (CART) therapy, for treating autoimmune disorders. Toward the end, the book examines the role of the gut microbiome on immune function and autoimmunity. It considers innovative drug delivery strategies as the future of personalized medicine in managing autoimmune diseases. This book is a valuable resource for researchers and students in immunology, microbiology, and pharmaceutical sciences.
Key Features
- Explores promising new frontiers in next-generation immunotherapy for autoimmune diseases
- Reviews the role of factors leading to the loss of immune tolerance and existing autoimmune disease management
- Examines innovative drug delivery strategies and the therapeutic potential of nutraceuticals against autoimmune diseases
- Reviews the role and therapeutic potential of gut microbiome in autoimmune disorders
- Presents the therapeutic potential of Tregs, chimeric antigen receptor T-cell therapy, and myeloid-derived suppressor cells in treating autoimmune diseases
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover Page
- Half-Title Page
- Title Page
- Copyright Page
- Contents
- About editor
- Introduction
- 1 Tolerance
- 2 Breakdown of tolerance
- 3 Autoimmunity
- 4 Current strategies to treat autoimmune diseases and their drawbacks
- 5 Immunotherapeutic approaches
- 6 Treg generation and their role in immunosuppression
- 7 Vaccines for autoimmune diseases
- 8 The significance of myeloid-derived suppressor cells (MDSCs) in autoimmune disorders
- 9 Revolutionizing autoimmune disease treatment by CAR T-cell therapy
- 10 Unlocking the nexus of gut microbiomes and autoimmune diseases
- 11 Exploring the therapeutic potential of nutraceuticals in autoimmune disease management
- 12 Advancing therapeutic frontiers with innovative drug delivery strategies in autoimmune disease management
- 13 Comprehensive exploration of T follicular regulatory cells in autoimmunity
- 14 Future therapies for autoimmune diseases
- 15 Orchestrating autoimmune diseases through nuclear receptors and orphan GPCRs
- Concluding remarks
- Index